Bayer

NCT07515339

Phase 1Withdrawn0 people7 Apr 2026clinicaltrials.gov

A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease

Phase 1Not yet recruiting36 people24 Feb 2026clinicaltrials.gov

NCT07270367

CollaboratorPhase 3Not yet recruiting156 people8 Dec 2025clinicaltrials.gov

NCT07192952

Phase 3Recruiting117 people25 Sept 2025clinicaltrials.gov

NCT07188805

Phase 3Recruiting111 people23 Sept 2025clinicaltrials.gov

NCT07155694

CollaboratorPhase 4Not yet recruiting30 people4 Sept 2025clinicaltrials.gov

NCT07142551

CollaboratorPhase 2Recruiting60 people26 Aug 2025clinicaltrials.gov

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

CollaboratorNo phaseRecruiting212 people2 Apr 2025clinicaltrials.gov

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

CollaboratorNo phaseRecruiting500 people2 Apr 2025clinicaltrials.gov

NCT06655194

Phase 1Completed38 people23 Oct 2024clinicaltrials.gov

NCT06594926

CollaboratorPhase 2Recruiting69 people19 Sept 2024clinicaltrials.gov

NCT06452277

Phase 3Recruiting555 people11 Jun 2024clinicaltrials.gov

NCT06329895

Phase 1Completed15 people26 Mar 2024clinicaltrials.gov

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

CollaboratorPhase 2Active, not recruiting127 people29 Feb 2024clinicaltrials.gov

NCT06244758

CollaboratorPhase 3Completed91 people6 Feb 2024clinicaltrials.gov

NCT06059664

CollaboratorPhase 2Recruiting100 people29 Sept 2023clinicaltrials.gov

NCT06008197

CollaboratorPhase 3Recruiting5,200 people23 Aug 2023clinicaltrials.gov

NCT05901831

Phase 3Completed241 people13 Jun 2023clinicaltrials.gov

NCT05705271

Phase 4Completed200 people30 Jan 2023clinicaltrials.gov

NCT05457283

Phase 3Recruiting100 people13 Jul 2022clinicaltrials.gov